FDA Panel Reviews MDMA Therapy for PTSD Approval
TL;DR Summary
An FDA advisory panel is reviewing whether to approve MDMA, also known as Ecstasy, for treating PTSD. The panel will consider evidence from clinical trials submitted by Lykos Therapeutics to determine if the benefits of MDMA therapy outweigh the risks. This decision could impact millions of Americans suffering from PTSD, including military veterans.
- FDA Panel Weighs MDMA Therapy for PTSD The New York Times
- FDA advisers consider MDMA therapy to treat PTSD CNN
- MDMA for PTSD: What's going on with federal approval? Vox.com
- Psychedelics Are Challenging the Scientific Gold Standard The Atlantic
- Ecstasy as a PTSD treatment? The FDA is set to decide. POLITICO
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 2 min read
Condensed
86%
389 → 53 words
Want the full story? Read the original article
Read on The New York Times